| Balance sheet (USD) | Q2 2026 ended Sep 30, 2025 | Q2 2025 ended Sep 30, 2024 | Q2 2025 ended Sep 30, 2023 |
|---|---|---|---|
| Total assets | 12.81M | 2.25M | |
| Total liabilities | 943.1K | 3.51M |
From Psyence Biomedical Ltd.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.